Parkway Pantai provides specialised Macular Degeneration Treatment using contemporary retinal technologies and evidence-based ophthalmic care. Founded in 1974, the JCI, MSQH accredited hospital is based in Kuala Lumpur, Malaysia, with 499 beds and services for domestic and international patients.

Treatment is tailored to the type and stage of macular degeneration. For wet AMD, intravitreal anti-VEGF medicines can help reduce abnormal blood vessel growth and fluid leakage in the retina. Selected patients may also require photodynamic therapy or other retinal interventions. Before treatment, specialists perform OCT scans and detailed retinal examinations.